Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.
Rodríguez-Frade JM, del Real G, Serrano A, Hernanz-Falcón P, Soriano SF, Vila-Coro AJ, de Ana AM, Lucas P, Prieto I, Martínez-A C, Mellado M.
Rodríguez-Frade JM, et al. Among authors: mellado m.
EMBO J. 2004 Jan 14;23(1):66-76. doi: 10.1038/sj.emboj.7600020. Epub 2003 Dec 11.
EMBO J. 2004.
PMID: 14685276
Free PMC article.